ArticleBrain and behavior2025
Epidemiology of Parkinson's Disease in Germany Between 2016 and 2021 Based on Statutory Health Insurance Claims Data.
Article in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comparative study of refractive errors between patients with Parkinson's disease versus age- and sex-matched healthy controls.BMC neurology · 2026Article
- Epidemiology of Parkinson's Disease in Germany Between 2016 and 2021 Based on Statutory Health Insurance Claims Data.Brain and behavior · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionParkinson's disease (PD) is a fast-growing neurodegenerative disease causing a high burden on national health systems. There is a lack of contemporary, reliable epidemiological data for PD in Germany. The aim of this study was to estimate the incidence and prevalence of PD in Germany for the years 2016-2021.
methodsThis is a secondary data analysis of anonymized health claims data from a subset of German statutory health insurances (SHIs) for the years 2016-2021. Data were then extrapolated to represent the full SHI population.
resultsFrom 2016 to 2021, PD prevalence in the study population increased from 494 to 511 patients per 100,000 (p = 0.0067). Incident patients showed no change overall but notably decreased from 2019 to 2020. In contrast, PD prevalence in the extrapolated cohort declined significantly during the same period, dropping from 575 to 501 patients per 100,000 (p < 0.0001). Similarly, PD incidence decreased from 69 to 60 patients per 100,000 (p = 0.0001).
conclusionsPD prevalence increased in the study population but declined in the extrapolated cohort, while incidence remained stable overall in the study population, yet decreased in the extrapolated cohort. This study provides key insights into the epidemiology of PD in Germany, highlighting the influence of methodology and the need for ongoing monitoring to inform healthcare planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.